优宁维(301166)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

301166 优宁维

已收盘 07-30 15:00:00

{"stockData":{"symbol":"301166","market":"SZ","secType":"STK","nameCN":"优宁维","latestPrice":33.18,"timestamp":1753858986000,"preClose":33.35,"halted":0,"volume":1961901,"delay":0,"changeRate":-0.0051,"floatShares":56202600,"shares":86666700,"eps":-0.0146,"marketStatus":"已收盘","change":-0.17,"latestTime":"07-30 15:00:00","open":33.24,"high":33.72,"low":32.8,"amount":65318200,"amplitude":0.0276,"askPrice":33.22,"askSize":5,"bidPrice":33.18,"bidSize":2,"shortable":0,"etf":0,"ttmEps":-0.0146,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753925400000},"marketStatusCode":5,"adr":0,"adjPreClose":33.35,"symbolType":"stock","openAndCloseTimeList":[[1753839000000,1753846200000],[1753851600000,1753858800000]],"highLimit":36.69,"lowLimit":30.02,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":86666668,"isCdr":false,"pbRate":1.41,"roa":"--","roe":"--","epsLYR":0.12,"committee":0.086758,"marketValue":2876000000,"turnoverRate":0.0349,"status":1,"floatMarketCap":1865000000},"requestUrl":"/m/hq/s/301166","defaultTab":"news","newsList":[{"id":"2555676060","title":"【机构调研记录】中信建投调研统联精密、优宁维等3只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2555676060","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555676060?lang=zh_cn&edition=full","pubTime":"2025-07-30 08:01","pubTimestamp":1753833679,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及7月29日披露的机构调研信息，中信建投近期对3家上市公司进行了调研，相关名单如下：1）统联精密 调研纪要：统联精密的主要收入来自消费电子领域，客户包括国内外知名企业和EMS厂商。旗下最近一年表现最佳的公募基金产品为中信建投价值增长A，最新单位净值为1.04，近一年增长22.69%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025073000005445.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688210","BK0250","601066","301166","BK0276","BK0214"],"gpt_icon":0},{"id":"2555679650","title":"【私募调研记录】中金银海调研优宁维","url":"https://stock-news.laohu8.com/highlight/detail?id=2555679650","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555679650?lang=zh_cn&edition=full","pubTime":"2025-07-30 08:01","pubTimestamp":1753833675,"startTime":"0","endTime":"0","summary":"根据市场公开信息及7月29日披露的机构调研信息，知名私募中金银海近期对1家上市公司进行了调研，相关名单如下：1）优宁维 调研纪要：公司作为生命科学一站式服务商，提供试剂、耗材、仪器、实验室服务等产品及服务，以代理产品为主、自主品牌产品为辅。中金银海专注于二级市场的证券投资，核心团队成员为何军民等业内资深专业人士，力争成为中国领先的私募证券基金管理公司。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2025073000005435.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301166"],"gpt_icon":0},{"id":"2555031187","title":"优宁维：有知名机构磐耀资产参与的多家机构于7月29日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2555031187","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555031187?lang=zh_cn&edition=full","pubTime":"2025-07-29 17:31","pubTimestamp":1753781489,"startTime":"0","endTime":"0","summary":"证券之星消息，2025年7月29日优宁维发布公告称民生证券、磐耀资产、中广云投资、中金银海、朝昔金融、华泰证券、中信建投、元一产融、天琛资本于2025年7月29日调研我司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072900029274.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301166"],"gpt_icon":0},{"id":"2551146272","title":"优宁维：7月16日接受机构调研，中信证券、易方达基金参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2551146272","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551146272?lang=zh_cn&edition=full","pubTime":"2025-07-16 17:01","pubTimestamp":1752656500,"startTime":"0","endTime":"0","summary":"证券之星消息，2025年7月16日优宁维发布公告称公司于2025年7月16日接受机构调研，中信证券、易方达基金参与。优宁维主营业务：公司面向高等院校、科研院所、医院和生物医药企业等,提供以抗体为核心的生命科学试剂及相关仪器、耗材和综合技术服务。优宁维2025年一季报显示，公司主营收入2.16亿元，同比下降20.34%；归母净利润-620.87万元，同比下降219.34%；扣非净利润-928.36万元，同比下降2696.56%；负债率8.57%，投资收益154.09万元，财务费用-84.83万元，毛利率18.12%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071600026991.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1064131003.USD","BK0276","600030","LU2289578879.USD","LU1794554557.SGD","BK1147","LU1997244956.HKD","BK0012","LU0405327148.USD","BK1564","BK1516","BK0188","06030","LU0405327494.USD","LU1328615791.USD","LU1720050803.USD","BK0196","LU1064130708.USD","LU1655091616.SGD","301166","LU2495084118.USD","BK0028","LU2148510915.USD","LU1997245094.SGD","BK1521","LU1997245177.USD","BK0183","BK0250"],"gpt_icon":0},{"id":"2551914540","title":"优宁维：股东信息查询需提供书面文件并核实身份","url":"https://stock-news.laohu8.com/highlight/detail?id=2551914540","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551914540?lang=zh_cn&edition=full","pubTime":"2025-07-16 16:31","pubTimestamp":1752654662,"startTime":"0","endTime":"0","summary":"证券之星消息，优宁维07月16日在投资者关系平台上答复投资者关心的问题。根据公司章程的规定：股东提出查阅股东人数等股东名册相关信息，应当向公司提供证明其持有公司股份的种类以及持股数量的书面文件，公司经核实股东身份后按照股东的要求予以提供。故其他时点股东信息的信息查询，需提供上述相关书面文件，并经公司核实股东身份后予以提供。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071600025899.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301166","BK0250"],"gpt_icon":0},{"id":"2550360541","title":"优宁维上涨6.33%，报33.42元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2550360541","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550360541?lang=zh_cn&edition=full","pubTime":"2025-07-11 09:55","pubTimestamp":1752198932,"startTime":"0","endTime":"0","summary":"7月11日，优宁维盘中上涨6.33%，截至09:55，报33.42元/股，成交2505.26万元，换手率1.39%，总市值28.96亿元。截至9月30日，优宁维股东户数1.2万，人均流通股3437股。2024年1月-9月，优宁维实现营业收入8.28亿元，同比减少6.60%；归属净利润1407.91万元，同比减少65.05%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/11095551620137.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["301166","BK0250"],"gpt_icon":0},{"id":"2548893567","title":"7月2日优宁维发布公告，股东减持72.96万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2548893567","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548893567?lang=zh_cn&edition=full","pubTime":"2025-07-02 18:01","pubTimestamp":1751450481,"startTime":"0","endTime":"0","summary":"证券之星消息，7月2日优宁维发布公告《优宁维:关于股东减持计划实施完成的公告》，其股东上海创业接力泰礼创业投资中心(有限合伙)于2025年6月11日至2025年7月2日间合计减持72.96万股，占公司目前总股本的0.8418%，变动期间该股股价上涨1.53%，截止7月1日收盘报30.54元。股东增减持详情见下表：根据优宁维2025年一季报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070200030252.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301166","BK0250"],"gpt_icon":0},{"id":"2548607265","title":"优宁维7月1日现2笔大宗交易 总成交金额742.55万元 溢价率为-9.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548607265","media":"新浪证券-红岸工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548607265?lang=zh_cn&edition=full","pubTime":"2025-07-01 17:00","pubTimestamp":1751360400,"startTime":"0","endTime":"0","summary":"　　7月1日，优宁维收跌0.16%，收盘价为30.54元，发生2笔大宗交易，合计成交量26.72万股，成交金额742.55万元。　　第1笔成交价格为27.79元，成交7.72万股，成交金额214.54万元，溢价率为-9.00%，买方营业部为华泰证券股份有限公司南京中山东路第二证券营业部，卖方营业部为申万宏源证券有限公司上海闵行区莘松路证券营业部。　　进一步统计，近3个月内该股累计发生14笔大宗交易，合计成交金额为4701.24万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2025-07-01/doc-infcyiik3378490.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["301166","BK0250"],"gpt_icon":0},{"id":"2547356580","title":"优宁维（301166）1493.37万股限售股将于6月30日解禁，占总股本17.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2547356580","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547356580?lang=zh_cn&edition=full","pubTime":"2025-06-30 08:02","pubTimestamp":1751241779,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，优宁维于6月30日将有1493.37万股限售股份解禁，为公司首发原股东限售股份,追加承诺限售股份上市流通，占公司总股本17.23%。本次解禁后，公司还有3046.41万股限售股份，占总股本35.15%。优宁维主营业务：公司面向高等院校、科研院所、医院和生物医药企业等,提供以抗体为核心的生命科学试剂及相关仪器、耗材和综合技术服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025063000001983.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301166","BK0250"],"gpt_icon":0},{"id":"2546715939","title":"6月27日优宁维现273.6万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2546715939","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546715939?lang=zh_cn&edition=full","pubTime":"2025-06-27 17:10","pubTimestamp":1751015452,"startTime":"0","endTime":"0","summary":"证券之星消息，6月27日优宁维发生大宗交易，交易数据如下：大宗交易成交价格27.36元，相对当日收盘价折价9.01%，成交10万股，成交金额273.6万元，买方营业部为华泰证券股份有限公司南京中山东路第二证券营业部，卖方营业部为申万宏源证券有限公司上海闵行区莘松路证券营业部。近三个月该股共发生11笔大宗交易，合计成交1.15万手，折价成交11笔。截至2025年6月27日收盘，优宁维报收于30.07元，上涨0.43%，换手率1.83%，成交量7543.0手，成交额2271.24万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062700028218.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301166"],"gpt_icon":0},{"id":"2546290353","title":"优宁维(301166.SZ)4539.78万股限售股将于6月30日上市流通","url":"https://stock-news.laohu8.com/highlight/detail?id=2546290353","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546290353?lang=zh_cn&edition=full","pubTime":"2025-06-25 17:12","pubTimestamp":1750842755,"startTime":"0","endTime":"0","summary":"智通财经APP讯，优宁维(301166.SZ)公告，公司首次公开发行前已发行股份本次解除限售数量为4539.78万股，占公司发行后总股本的52.38%，上市流通日期顺延至2025年6月30日(星期一)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1309536.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301166","BK0250"],"gpt_icon":0},{"id":"2543650238","title":"每周股票复盘：优宁维（301166）股东减持46.24万股，注销募集资金专户","url":"https://stock-news.laohu8.com/highlight/detail?id=2543650238","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543650238?lang=zh_cn&edition=full","pubTime":"2025-06-14 13:37","pubTimestamp":1749879427,"startTime":"0","endTime":"0","summary":"截至2025年6月13日收盘，优宁维报收于29.86元，较上周的29.86元上涨0.0%。本周，优宁维6月10日盘中最高价报30.65元。公司公告汇总上海优宁维生物科技股份有限公司关于注销募集资金专项账户的公告。截至本公告日，上述募集资金专户已完成注销手续，相关监管协议也随之终止。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061400012982.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301166","BK0250"],"gpt_icon":0},{"id":"2542311156","title":"6月10日优宁维发布公告，股东减持46.24万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2542311156","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542311156?lang=zh_cn&edition=full","pubTime":"2025-06-10 20:02","pubTimestamp":1749556931,"startTime":"0","endTime":"0","summary":"证券之星消息，6月10日优宁维发布公告《优宁维:关于股东权益变动的提示性公告》，其股东上海创业接力泰礼创业投资中心(有限合伙)、上海泰礼创业投资管理有限公司-上海含泰创业投资合伙企业(有限合伙)于2025年6月6日至2025年6月10日间合计减持46.24万股，占公司目前总股本的0.5336%，变动期间该股股价上涨1.14%，截止6月10日收盘报30.08元。股东增减持详情见下表：根据优宁维2025年一季报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061000032934.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301166"],"gpt_icon":0},{"id":"2542880263","title":"6月9日优宁维发生1笔大宗交易 成交金额657.6万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542880263","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542880263?lang=zh_cn&edition=full","pubTime":"2025-06-09 17:11","pubTimestamp":1749460286,"startTime":"0","endTime":"0","summary":"证券之星消息，6月9日优宁维发生大宗交易，交易数据如下：大宗交易成交价格27.4元，相对当日收盘价折价9.42%，成交24万股，成交金额657.6万元，买方营业部为万联证券股份有限公司北京分公司，卖方营业部为申万宏源证券有限公司上海闵行区莘松路证券营业部。近三个月该股共发生10笔大宗交易，合计成交1.05万手，折价成交10笔。截至2025年6月9日收盘，优宁维报收于30.25元，上涨1.31%，换手率3.43%，成交量1.42万手，成交额4285.62万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060900021665.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301166","BK0250"],"gpt_icon":0},{"id":"2541837869","title":"6月6日优宁维现2笔大宗交易 机构净买入201.06万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541837869","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541837869?lang=zh_cn&edition=full","pubTime":"2025-06-06 17:08","pubTimestamp":1749200939,"startTime":"0","endTime":"0","summary":"证券之星消息，6月6日优宁维发生大宗交易，交易数据如下：近三个月该股共发生9笔大宗交易，合计成交8075.0手，折价成交9笔。该股近期无解禁股上市。截至2025年6月6日收盘，优宁维(301166)报收于29.86元，上涨0.4%，换手率2.09%，成交量8635.0手，成交额2568.96万元。该股近半年内有股东持股变动，合计净减持138.0万股，股东增减持明细如下表：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060600025865.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301166"],"gpt_icon":0},{"id":"2541157028","title":"优宁维(301166.SZ)遭股东泰礼投资及含泰投资减持1.41%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2541157028","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541157028?lang=zh_cn&edition=full","pubTime":"2025-06-05 17:07","pubTimestamp":1749114477,"startTime":"0","endTime":"0","summary":"智通财经APP讯，优宁维(301166.SZ)公告，公司股东上海创业接力泰礼创业投资中心(有限合伙)(简称“泰礼投资”)及其一致行动人上海泰礼创业投资管理有限公司-上海含泰创业投资合伙企业(有限合伙)(简称“含泰投资”)通过集中竞价方式和大宗交易方式合计减持公司股份120.85万股，占公司扣除回购专户股份后总股本的1.41%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1301714.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"优宁维(301166.SZ)遭股东泰礼投资及含泰投资减持1.41%股份","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301166","BK0250"],"gpt_icon":0},{"id":"2541886042","title":"优宁维：公司客户主要为国内高等院校、科研院所、医院和生物医药企业等","url":"https://stock-news.laohu8.com/highlight/detail?id=2541886042","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541886042?lang=zh_cn&edition=full","pubTime":"2025-06-05 16:24","pubTimestamp":1749111849,"startTime":"0","endTime":"0","summary":"证券之星消息，优宁维(301166)06月05日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好，请问咱们公司与舒泰神，三生国健等国内优秀创新药企业有合作吗？优宁维回复：投资者您好，公司客户主要为国内高等院校、科研院所、医院和生物医药企业等，其中生物医药企业是公司的重要客户组成，公司致力于为生命科学领域客户提供科研一站式产品和服务，目前产品主要广泛应用于基础生命科学科研领域。谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060500022553.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161726","399441","BK0250","301166"],"gpt_icon":0},{"id":"2537294992","title":"优宁维：公司持续加大对自主品牌产品研发投入","url":"https://stock-news.laohu8.com/highlight/detail?id=2537294992","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537294992?lang=zh_cn&edition=full","pubTime":"2025-05-22 20:48","pubTimestamp":1747918139,"startTime":"0","endTime":"0","summary":"证券之星消息，优宁维05月22日在投资者关系平台上答复投资者关心的问题。股价方面的影响因素是多方面的，除了公司自身业绩因素外，还受多种因素影响，公司提醒投资者注意投资风险。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052200035153.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301166","BK0250"],"gpt_icon":0},{"id":"2537992247","title":"优宁维：公司如有开展投资收购等事项会按照信息披露的相关要求及时履行信息披露义务","url":"https://stock-news.laohu8.com/highlight/detail?id=2537992247","media":"证券之星","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537992247?lang=zh_cn&edition=full","pubTime":"2025-05-22 15:39","pubTimestamp":1747899566,"startTime":"0","endTime":"0","summary":"证券之星消息，优宁维(301166)05月22日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘，您好！请问贵公司最近有没有资产重组计划在进行，公司效益前景如何？优宁维回复：投资者您好！公司如有开展投资收购等事项会按照信息披露的相关要求及时履行信息披露义务，感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052200018877.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301166"],"gpt_icon":0},{"id":"2535817645","title":"优宁维收盘上涨1.84%，最新市净率1.24，总市值25.41亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535817645","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535817645?lang=zh_cn&edition=full","pubTime":"2025-05-15 18:11","pubTimestamp":1747303917,"startTime":"0","endTime":"0","summary":"5月15日，优宁维今日收盘29.32元，上涨1.84%，最新市净率1.24，创27天以来新低，总市值25.41亿元。资金流向方面，5月15日，优宁维主力资金净流入376.89万元，近5日总体呈流入状态，5日共流入437.72万元。上海优宁维生物科技股份有限公司的主营业务是提供以抗体为核心的生命科学试剂及相关仪器、耗材和综合技术服务。最新一期业绩显示，2025年一季报，公司实现营业收入2.16亿元，同比-20.34%；净利润-6208677.82元，同比-219.34%，销售毛利率18.12%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/05/15181150415503.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0250","301166"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1753881368496,"stockEarnings":[{"period":"1week","weight":0.0277},{"period":"1month","weight":0.1091},{"period":"3month","weight":0.2041},{"period":"6month","weight":0.2119},{"period":"1year","weight":0.2768},{"period":"ytd","weight":0.1842}],"compareEarnings":[{"period":"1week","weight":0.0078},{"period":"1month","weight":0.0542},{"period":"3month","weight":0.1008},{"period":"6month","weight":0.1105},{"period":"1year","weight":0.2482},{"period":"ytd","weight":0.077}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海优宁维生物科技股份有限公司","boardCode":"AI0051","boardName":"批发业","stockholders":"10851人(较上一季度增加0.18%)","perCapita":"5179股","listingDate":"2021-12-28","address":"上海市杨浦区控江路1690号1505室","registeredCapital":"8666万元","survey":"　　上海优宁维生物科技股份有限公司的主营业务是提供以抗体为核心的生命科学试剂及相关仪器、耗材和综合技术服务。公司的主要产品是生命科学试剂、生命科学仪器及耗材、综合技术服务。","listedPrice":86.06},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"优宁维(301166)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供优宁维(301166)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"优宁维,301166,优宁维股票,优宁维股票老虎,优宁维股票老虎国际,优宁维行情,优宁维股票行情,优宁维股价,优宁维股市,优宁维股票价格,优宁维股票交易,优宁维股票购买,优宁维股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"优宁维(301166)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供优宁维(301166)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}